Search Results

There are 16235 results for: content related to: Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

  1. You have free access to this content
    Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

    Hepatology

    Volume 49, Issue 5, May 2009, Pages: 1503–1514, Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick, Kevin A. Pokornowski, Betsy J. Eggers, Jie Fang, Michael J. Wichroski, Dong Xu, Joanna Yang, Richard B. Wilber and Richard J. Colonno

    Version of Record online : 4 FEB 2009, DOI: 10.1002/hep.22841

  2. You have free access to this content
    Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

    Hepatology

    Volume 47, Issue 5, May 2008, Pages: 1473–1482, Carl J. Baldick, Daniel J. Tenney, Charles E. Mazzucco, Betsy J. Eggers, Ronald E. Rose, Kevin A. Pokornowski, Cheng F. Yu and Richard J. Colonno

    Version of Record online : 14 JAN 2008, DOI: 10.1002/hep.22211

  3. You have free access to this content
    Poster Session 4: Hepatitis B Therapy

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1088A–1128A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27532

  4. You have free access to this content
    Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

    Hepatology

    Volume 54, Issue 1, July 2011, Pages: 91–100, Yun-Fan Liaw, Maria Raptopoulou-Gigi, Hugo Cheinquer, Shiv Kumar Sarin, Tawesak Tanwandee, Nancy Leung, Cheng-Yuan Peng, Robert P. Myers, Robert S. Brown Jr, Lennox Jeffers, Naoky Tsai, Jolanta Bialkowska, Shijie Tang, Suzanne Beebe and Elizabeth Cooney

    Version of Record online : 24 JUN 2011, DOI: 10.1002/hep.24361

  5. Economic analysis between entecavir and lamivudine for the treatment of chronic hepatitis B in Hong Kong

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 7, July 2012, Pages: 1167–1174, Kenneth KC Lee, David Bin Chia Wu, Pui Yu Chow, Vivian Wing Yan Lee and Hong Li

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1440-1746.2011.07047.x

  6. Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 1, July 2016, Pages: 16–34, P. Lampertico, H. L. Y. Chan, H. L. A. Janssen, S. I. Strasser, R. Schindler and T. Berg

    Version of Record online : 19 MAY 2016, DOI: 10.1111/apt.13659

  7. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26856

  8. Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 1, January 2014, Pages: 185–192, Rong-Nan Chien, Cheng-Yuan Peng, Jia-Horng Kao, Tsung-Hui Hu, Chun-Che Lin, Chi-Tan Hu, Chi-Yi Chen, Tsai-Yuan Hsieh, Han-Chieh Lin, Wan-Long Chuang and on behalf of the Taiwan NA-Registry Group

    Version of Record online : 19 DEC 2013, DOI: 10.1111/jgh.12416

  9. You have free access to this content
    Economic Implications of Entecavir Treatment in Suppressing Viral Replication in Chronic Hepatitis B (CHB) Patients in China from a Perspective of the Chinese Social Security Program

    Value in Health

    Volume 11, Issue s1, March/April 2008, Pages: S11–S22, Yong Yuan, Uchenna Iloeje, Hong Li, Joel Hay and Guang B. Yao

    Version of Record online : 2 APR 2008, DOI: 10.1111/j.1524-4733.2008.00362.x

  10. Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine

    Hepatology Research

    Volume 41, Issue 5, May 2011, Pages: 405–416, Haruhiko Kobashi, Yasuhiro Miyake, Fusao Ikeda, Tetsuya Yasunaka, Ken Nishino, Akio Moriya, Jyunichi Kubota, Shinichiro Nakamura, Akinobu Takaki, Kazuhiro Nouso, Gotaro Yamada and Kazuhide Yamamoto

    Version of Record online : 21 MAR 2011, DOI: 10.1111/j.1872-034X.2011.00785.x

  11. Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 7, July 2014, Pages: 1485–1493, Jeong Heo, Sang Hoon Ahn, Young-Oh Kweon, Byung-Ho Kim, Henry L Y Chan, Andrzej Horban, Suchat Wongcharatrawee, Cyril Llamoso and Kwan Sik Lee

    Version of Record online : 15 JUL 2014, DOI: 10.1111/jgh.12567

  12. Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009

    Hepatology Research

    Volume 41, Issue 1, January 2011, Pages: 1–21, Osamu Yokosuka, Masayuki Kurosaki, Fumio Imazeki, Yasuji Arase, Yasuhito Tanaka, Kazuaki Chayama, Eiji Tanaka, Hiromitsu Kumada, Namiki Izumi, Masashi Mizokami and Masatoshi Kudo

    Version of Record online : 11 NOV 2010, DOI: 10.1111/j.1872-034X.2010.00739.x

  13. Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir

    Journal of Viral Hepatitis

    Volume 22, Issue 8, August 2015, Pages: 675–681, L. Lu, B. Yip, H. Trinh, C. Q. Pan, S.-H. B. Han, C. C. Wong, J. Li, S. Chan, G. Krishnan, C. C. Wong and M. H. Nguyen

    Version of Record online : 24 NOV 2014, DOI: 10.1111/jvh.12368

  14. You have full text access to this OnlineOpen article
    Efficacy and safety of entecavir treatment in a heterogeneous CHB population from a ‘real-world’ clinical practice setting in China

    Journal of Viral Hepatitis

    Volume 20, Issue 11, November 2013, Pages: 811–820, J.-L. Hou, J.-D. Jia, L. Wei, W. Zhao, Y. M. Wang, M. Cheng, X. Tang, D.-M. Tan, H. Ren, H. Tang, D. Cohen and C. Llamoso

    Version of Record online : 29 MAY 2013, DOI: 10.1111/jvh.12115

  15. Comparison of the efficacies of entecavir 0.5 and 1.0 mg combined with adefovir in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analogue treatments

    Journal of Medical Virology

    Volume 87, Issue 6, June 2015, Pages: 999–1007, Yuri Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Hyo-Suk Lee and Yoon Jun Kim

    Version of Record online : 24 FEB 2015, DOI: 10.1002/jmv.24150

  16. New Hybrid Semiconductor Materials Based on Viologen Salts of Bimetallic Fe–Pt and Fe–Au Carbonyl Clusters: First Structural Characterization of the Diradical π-Dimer of the Diethylviologen Monocation and EPR Evidence of its Triplet State

    Chemistry - A European Journal

    Volume 13, Issue 23, August 6, 2007, Pages: 6544–6554, Cristina Femoni, Maria Carmela Iapalucci, Giuliano Longoni, Cristina Tiozzo, Joanna Wolowska, Stefano Zacchini and Enrico Zazzaroni

    Version of Record online : 5 JUL 2007, DOI: 10.1002/chem.200700398

  17. Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy

    Liver International

    Volume 35, Issue 11, November 2015, Pages: 2370–2383, Young E. Chon, Bora Jin, Sang H. Ahn, Seungtaek Kim, Nam D. Kim, Jeon H. Park, Chung M. Nam, Kyun-Hwan Kim, Sun P. Hong, Sung H. Choi, Do Y. Kim, Jun Y. Park and Kwang-Hyub Han

    Version of Record online : 13 MAY 2015, DOI: 10.1111/liv.12845

  18. The Chemistry of Ni–Sb Carbonyl Clusters – Synthesis and Characterization of the [Ni19Sb4(CO)26]4– Tetraanion and the Viologen Salts of [Ni13Sb2(CO)24]n– Carbonyl Clusters

    European Journal of Inorganic Chemistry

    Volume 2014, Issue 25, September 2014, Pages: 4151–4158, Cristina Femoni, Maria Carmela Iapalucci, Giuliano Longoni, Stefano Zacchini, Iacopo Ciabatti, Raffaele Guido Della Valle, Marcello Mazzani and Mauro Riccò

    Version of Record online : 17 JUL 2014, DOI: 10.1002/ejic.201402289

  19. Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: Clonal evolution during lamivudine plus adefovir therapy

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 55–64, Soon Sun Kim, Sung Won Cho, Soo-Ok Kim, Sun Pyo Hong and Jae Youn Cheong

    Version of Record online : 23 OCT 2012, DOI: 10.1002/jmv.23440

  20. 4′-modified nucleoside analogs: Potent inhibitors active against entecavir-resistant hepatitis B virus

    Hepatology

    Volume 62, Issue 4, October 2015, Pages: 1024–1036, Yuki Takamatsu, Yasuhito Tanaka, Satoru Kohgo, Shuko Murakami, Kamalendra Singh, Debananda Das, David J. Venzon, Masayuki Amano, Nobuyo Higashi-Kuwata, Manabu Aoki, Nicole S. Delino, Sanae Hayashi, Satoru Takahashi, Yoshikazu Sukenaga, Kazuhiro Haraguchi, Stefan G. Sarafianos, Kenji Maeda and Hiroaki Mitsuya

    Version of Record online : 25 AUG 2015, DOI: 10.1002/hep.27962